SRPT

NASDAQ 已收盘

Sarepta Therapeutics

14.17 USD
▼-0.36-2.48%
盘后 14.20 +0.21%
2026-11-19
市值
$1.43B
市盈率
25.69
EPS
-1.09
股息率
—
52 周区间
14.07 – 24.68
成交量
2.07M
Beta
0.46
目标价
21.86
52W 低 14.0752W 高 24.68
价格走势

公司简介

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; ...

关联新闻